Hualan Vac(SZ:301207) Zhong Guo Jing Ji Wang·2025-12-04 07:12Core Viewpoint - The announcement from the China Securities Index Co., Ltd. regarding the adjustment of sample stocks for various indices, including the Shenzhen Component Index and ChiNext Index, indicates that Hualan Biological Engineering Inc. (华兰疫苗) will be removed from the Shenzhen Component Index as of December 15, 2025 [1] Group 1: Company Overview - Hualan Biological Engineering Inc. was listed on the Shenzhen Stock Exchange's ChiNext on February 18, 2022, with an initial public offering (IPO) of 40.01 million shares at a price of 56.88 RMB per share [2] - The stock reached a peak of 79.78 RMB on its first trading day but is currently trading below its IPO price, indicating a state of loss [2] - The total funds raised from the IPO amounted to 2.276 billion RMB, with a net amount of 2.244 billion RMB after deducting issuance costs [2][3] Group 2: Financial Performance - The company initially planned to raise 2.495 billion RMB, but the actual amount raised was 251 million RMB less than expected [2] - Hualan Biological's 2022 annual equity distribution plan included a cash dividend of 3.00 RMB per 10 shares and a capital reserve conversion of 5 additional shares for every 10 shares held [3][4] - The company has a registered capital of 601.0275 million RMB and paid-in capital of 360 million RMB [4]